Nasdaq · CIK 0001560258
ECOR electroCore, Inc.
Insider trading from SEC Form 4. Last filing 21 d ago. Close $9.66 on Oct 9, 2026, +119% from the 52-week low and -21% from the high.
electroCore, Inc. (ECOR) has 35 SEC Form 4 filings on file from 10 insiders, the latest filed on Sep 22, 2026. In the last 90 days insiders made 2 open-market buys worth $98k and 0 open-market sells worth $0, net +$98k.
14 open-market trades have been scored at ECOR. The newest: Thomas J. Errico (director) bought $49k of stock on Sep 14, 2026, filed Sep 22, 2026, scored 30 (weak). The largest of the 14 shown: Daniel S Goldberger (Chief Executive Officer) sold $544k on Apr 23, 2026, scored 37 (weak). 2 insiders bought within 14 days of each other around Sep 14, 2026.
ECOR closed at $9.66 on Oct 9, 2026, 119% above its 52-week low and 21% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Mar 25, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at electroCore, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Thomas J. Errico director buy | $49k 5,000 shares | +1% | +121% from low-10% from high | |
| 30Weak | Michael Fox See Remarks buy | $49k 5,000 shares | +4% | +118% from low-11% from high | |
| 37Weak | Daniel S Goldberger Chief Executive Officer sell | $544k 80,000 shares | -27% | +43% from low-24% from high | |
| 26Weak | Thomas J. Errico director buy | $60k 9,992 shares | +3% | +39% from low-27% from high | |
| 18Weak | Daniel S Goldberger Chief Executive Officer sell | $97k 16,072 shares | -5% | +41% from low-25% from high | |
| 37Weak | Joshua S. Lev Chief Financial Officer sell | $13k 2,500 shares | -10% | +15% from low-74% from high | |
| 28Weak | Daniel S Goldberger Chief Executive Officer buy | $4,840 1,000 shares | +0% | +10% from low-75% from high | |
| 32Weak | Joshua S. Lev Chief Financial Officer sell | $13k 2,166 shares | -8% | +41% from low-69% from high | |
| 52Moderate | Thomas J. Errico director buy | $67k 15,000 shares | +6% | 0% from low-78% from high | |
| 46Moderate | Daniel S Goldberger Chief Executive Officer buy | $4,230 1,000 shares | +0% | 0% from low-78% from high | |
| 41Moderate | John P Gandolfo director buy | $9,018 1,800 shares | +3% | +8% from low-74% from high | |
| 53Moderate | Thomas J. Errico director buy | $48k 10,000 shares | +4% | +4% from low-75% from high | |
| 28Weak | Daniel S Goldberger Chief Executive Officer buy | $8,590 1,000 shares | +0% | - | |
| 30Weak | Thomas J. Errico director buy | $49k 6,000 shares | +2% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 25, 2025 | Theofilos Charles Steve Director | 65,000 0.90% of outstanding | $481k | Mar 25, 2025 | none |
Transactions
Every row filed, 41 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Thomas J. Errico director | POpen-market purchase Common Stock | +5,000 | $9.82 | $49k | 363,904 | 21 d ago |
| Sep 11, 2026 | Michael Fox See Remarks | POpen-market purchase Common Stock | +5,000 | $9.80 | $49k | 130,000 | 25 d ago |
| Sep 11, 2026 | Michael Fox See Remarks | AGrant or award Common Stock | +5,000 | $9.80 | $49k | 130,000 | 29 d ago |
| Sep 9, 2026 | Elena Bonfiglioli director | AGrant or award Common Stock | +11,123 | $0.00 | $0 | 41,672 | 33 d ago |
| Sep 9, 2026 | Thomas J. Errico director | AGrant or award Common Stock | +15,572 | $0.00 | $0 | 358,904 | 33 d ago |
| Sep 9, 2026 | John P Gandolfo director | AGrant or award Common Stock | +11,123 | $0.00 | $0 | 99,221 | 33 d ago |
| Sep 9, 2026 | Julie Ann Goldstein director | AGrant or award Common Stock | +11,123 | $0.00 | $0 | 112,510 | 33 d ago |
| Sep 9, 2026 | James Charles Theofilos director | AGrant or award Common Stock | +11,123 | $0.00 | $0 | 34,670 | 33 d ago |
| Sep 9, 2026 | Patricia Wilber director | AGrant or award Common Stock | +11,123 | $0.00 | $0 | 83,448 | 33 d ago |
| Sep 8, 2026 | Michael Fox See Remarks | AGrant or award Common Stock | +55,000 | $0.00 | $0 | 125,000 | 33 d ago |
| Sep 8, 2026 | Joshua S. Lev See Remarks | AGrant or award Common Stock | +55,000 | $0.00 | $0 | 139,889 | 33 d ago |
| Apr 23, 2026 | Daniel S Goldberger Chief Executive Officer | SOpen-market sale Common Stock | -80,000 | $6.80 | $544k | 211,471 | Jun 12, 2026 |
| May 20, 2026 | Thomas J. Errico director | LSmall acquisition Common Stock | +8 | $5.98 | $48 | 350,079 | May 26, 2026 |
| May 21, 2026 | Thomas J. Errico director | POpen-market purchase Common Stock | +9,992 | $5.99 | $60k | 360,071 | May 26, 2026 |
| Apr 13, 2026 | Michael Fox Chief Operating Officer | AGrant or award Common Stock | +70,000 | $0.00 | $0 | 70,000 | Apr 14, 2026 |
| Apr 10, 2026 | Daniel S Goldberger Chief Executive Officer | SOpen-market sale Common Stock | -16,072 | $6.02 | $97k | 291,471 | Apr 14, 2026 |
| Mar 19, 2026 | Thomas J. Errico director | XIn-the-money exercise Common Stock | +22,803 | $4.35 | $99k | 330,819 | Mar 20, 2026 |
| Mar 19, 2026 | Thomas J. Errico director | XIn-the-money exercise Common Stock | +19,252 | $6.43 | $124k | 350,071 | Mar 20, 2026 |
| Mar 19, 2026 | Thomas J. Errico director | XIn-the-money exercise Warrants to Purchase Common Stockderivative | +22,803 | $0.00 | $0 | 0 | Mar 20, 2026 |
| Mar 19, 2026 | Thomas J. Errico director | XIn-the-money exercise Warrants to Purchase Common Stockderivative | +19,252 | $0.00 | $0 | 0 | Mar 20, 2026 |
| Jan 26, 2026 | Daniel S Goldberger Chief Executive Officer | AGrant or award Common Stock | +20,375 | $7.47 | $152k | 312,940 | Jan 28, 2026 |
| Jan 26, 2026 | Joshua S. Lev Chief Financial Officer | AGrant or award Common Stock | +2,889 | $0.00 | $0 | 24,556 | Jan 28, 2026 |
| Jan 26, 2026 | Joshua S. Lev Chief Financial Officer | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 49,556 | Jan 28, 2026 |
| Jan 26, 2026 | Daniel S Goldberger Chief Executive Officer | AGrant or award Common Stock | +26,000 | $0.00 | $0 | 338,940 | Jan 28, 2026 |
| Dec 4, 2025 | Joshua S. Lev Chief Financial Officer | SOpen-market sale Common Stock | -2,500 | $5.05 | $13k | 21,667 | Dec 5, 2025 |
| Dec 2, 2025 | Daniel S Goldberger Chief Executive Officer | POpen-market purchase Common Stock | +1,000 | $4.84 | $4,840 | 292,565 | Dec 3, 2025 |
| Nov 12, 2025 | Joshua S. Lev Chief Financial Officer | SOpen-market sale Common Stock | -2,166 | $6.18 | $13k | 23,667 | Nov 14, 2025 |
| Sep 10, 2025 | Elena Bonfiglioli director | AGrant or award Common Stock | +30,549 | $0.00 | $0 | 30,549 | Sep 12, 2025 |
| Sep 2, 2025 | Thomas M Patton director | AGrant or award Common Stock | +19,011 | $0.00 | $0 | 102,782 | Sep 4, 2025 |
| Sep 2, 2025 | Patricia Wilber director | AGrant or award Common Stock | +19,011 | $0.00 | $0 | 72,325 | Sep 4, 2025 |
| Sep 2, 2025 | Julie Ann Goldstein director | AGrant or award Common Stock | +19,011 | $0.00 | $0 | 101,387 | Sep 4, 2025 |
| Sep 2, 2025 | John P Gandolfo director | AGrant or award Common Stock | +19,011 | $0.00 | $0 | 88,098 | Sep 4, 2025 |
| Sep 2, 2025 | Thomas J. Errico director | AGrant or award Common Stock | +26,615 | $0.00 | $0 | 308,016 | Sep 4, 2025 |
| Aug 11, 2025 | Thomas J. Errico director | POpen-market purchase Common Stock | +15,000 | $4.47 | $67k | 281,401 | Aug 13, 2025 |
| Aug 11, 2025 | Daniel S Goldberger Chief Executive Officer | POpen-market purchase Common Stock | +1,000 | $4.23 | $4,230 | 291,565 | Aug 12, 2025 |
| Aug 1, 2025 | James Charles Theofilos director | AGrant or award Common Stock | +22,156 | $0.00 | $0 | 23,547 | Aug 5, 2025 |
| May 23, 2025 | John P Gandolfo director | POpen-market purchase Common Stock | +1,800 | $5.01 | $9,018 | 69,087 | May 27, 2025 |
| May 12, 2025 | Thomas J. Errico director | POpen-market purchase Common Stock | +10,000 | $4.77 | $48k | 266,401 | May 13, 2025 |
| Mar 17, 2025 | Daniel S Goldberger Chief Executive Officer | POpen-market purchase Common Stock | +1,000 | $8.59 | $8,590 | 290,565 | Mar 18, 2025 |
| Mar 17, 2025 | Thomas J. Errico director | POpen-market purchase Common Stock | +6,000 | $8.10 | $49k | 256,401 | Mar 17, 2025 |
| Jan 18, 2025 | Daniel S Goldberger Chief Executive Officer | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 289,565 | Jan 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Elena Bonfigliolidirector
- Thomas J. Erricodirector
- Michael FoxChief Operating Officer
- John P Gandolfodirector
- Daniel S GoldbergerChief Executive Officer
- Julie Ann Goldsteindirector
- Joshua S. LevChief Financial Officer
- Thomas M Pattondirector
- James Charles Theofilosdirector
- Patricia Wilberdirector
Questions about ECOR
Answered from the filings on this page, as of the latest one.
Are insiders buying ECOR?
As of Sep 22, 2026, SEC Form 4 filings show 2 open-market buys worth $98k by 2 insiders and 0 open-market sells worth $0 by 0 insiders at electroCore, Inc. in the last 90 days, net +$98k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade ECOR on the open market?
Thomas J. Errico (director) bought $49k of ECOR on Sep 14, 2026 and filed the Form 4 on Sep 22, 2026. InsiderTell scored 30 (weak), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at electroCore, Inc.?
10 people have filed a Form 4 at electroCore, Inc., among them Elena Bonfiglioli (director), Thomas J. Errico (director), Michael Fox (Chief Operating Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.